Study start-up is one of the most demanding phases of clinical research. For sites managing large and diverse portfolios, success depends on getting the right information early and keeping communication clear as complexity increases. Continue Reading Article
For patients participating in rare disease and pediatric studies, clinical trial participation often extends far beyond the clinic visit itself. Travel, caregiving responsibilities, scheduling challenges, and years-long commitments can create significant burdens for patients and their families. Continue Reading Article
From Principles to Practice: Bringing the Playbook to Life The Collaborate Forward Playbook from SCRS outlines four pillars of successful collaboration: leadership support, operational impact, information governance, and feedback loops. Continue Reading Article
For sites, the reality of clinical research is defined by operations—how logistics, payments, travel, and participant support actually work in practice. When this layer works well, studies move forward with fewer disruptions. When it doesn’t, burden compounds quickly for sites and participants. Scout’s role is to absorb that complexity early, so it does not
Understanding Today’s Collaboration Challenges One of the biggest barriers to effective study collaboration is the disconnect in how sponsors, CROs, and sites think about technology. According to Ashley Davidson, VP and Product Lead for Sponsor Tech Solutions at Advarra, this gap appears in nearly every early customer conversation. Continue Reading Article
Medidata’s Site Insights Program reflects a deliberate shift toward transparency, efficiency, and true site-centricity in clinical research. Built on the belief that better technology starts with better listening, the program embeds the site voice into product design, training, and strategy. Every insight gathered is tied to action, ensuring that collaboration leads to measurable improvements
Merck’s approach to site partnerships has evolved in response to two key drivers: the growing complexity of clinical trials and the need to foster meaningful, sustainable collaborations with sites. What began as a traditional sponsor-led relationship has transformed into a collaborative model centered on core principles—communication, flexibility, transparency, and shared values. Continue Reading Article
As the clinical research industry continues evolving at a rapid pace, organizations are increasingly recognizing that meaningful progress happens when people lead with intention, humility, and openness. For Carlos Orantes, Chief Executive Officer, and Casey Orvin, Chief Commercial Officer, collaboration is not a strategy — it is a reflection of who Alcanza is. Guided
Through its Site Alliance evolution, Parexel demonstrates how a CRO can redefine accountability, foster transparency, and elevate site relationships. By adapting to sites’ changing needs, creating clear points of contact, and investing in emerging sites through curated efforts and mentoring programs, Parexel continues to advance a collaborative culture where sites feel heard, supported, and
In clinical research, collaboration can’t be an afterthought. It must be built into the process, from the first site contact to the last database lock. ProofPilot is proving what happens when that principle is taken seriously: collaboration by design. Built for Collaboration, Not Just Study Execution ProofPilot’s platform isn’t just another study management
